The desk / continuation
Dispatches 217–227 of 476; page 19 of 40.
A comprehensive clinical and harm-reduction guide to Quetiapine (Qutipin) in India, exploring its atypical antipsychotic mechanism, its misuse as a 'sleeper' or 'downer', Jan Aushadhi pricing, and the 2026 metabolic crisis.
GeneralA comprehensive clinical and harm-reduction guide to Bupropion (Bupron) in India, exploring its NDRI mechanism, its role in smoking cessation and Adult ADHD, Jan Aushadhi pricing, and the dose-dependent seizure risk as of 2026.
GeneralA comprehensive clinical and harm-reduction guide to Nandrolone in India, exploring its anabolic benefits in anemia, its widespread misuse in gyms, Jan Aushadhi pricing, and the risk of 'Deca Dick' and heart failure as of 2026.
GeneralA comprehensive clinical and harm-reduction guide to Testosterone in India, exploring its role in hormone replacement, its widespread misuse in the TRT and bodybuilding culture, Jan Aushadhi pricing, and the risk of permanent infertility as of 2026.
GeneralA comprehensive clinical and harm-reduction guide to Stanozolol in India, exploring its use in angioedema, its widespread misuse for 'cutting' in bodybuilding, Jan Aushadhi pricing, and the risk of liver failure and tendon ruptures as of 2026.
GeneralA comprehensive clinical and harm-reduction guide to Clenbuterol in India, exploring its role as a veterinary bronchodilator, its dangerous misuse for rapid weight loss, and the risk of permanent heart wall thickening as of 2026.
GeneralA comprehensive clinical and harm-reduction guide to Inhalants in India, exploring the industrial role of Toluene, the tragic epidemic of glue-sniffing among street children, and the risk of 'Sudden Sniffing Death Syndrome' as of 2026.
GeneralA comprehensive clinical and harm-reduction guide to Alkyl Nitrites (Poppers) in India, exploring their vasodilator mechanism, their use in the club and LGBTQ+ scenes, the 'Blue Blood' oxygen crisis, and the risk of permanent vision loss as of 2026.
GeneralA critical clinical and harm-reduction guide to Fentanyl in the Indian landscape, covering its extreme potency, transdermal patch technology, market pricing, and the risk of 'Wooden Chest' syndrome as of 2026.
GeneralA comprehensive clinical and harm-reduction guide to Cannabis in India, exploring the medical potential of CBD, the legal distinction between Bhang and Ganja, and the rising 2026 risks of high-THC psychosis and CHS.
GeneralA comprehensive clinical and harm-reduction guide to Buprenorphine in India, covering its unique 'Ceiling Effect', its role in Opioid Substitution Therapy (OST), market pricing, and the risks of precipitated withdrawal as of 2026.
GeneralA comprehensive clinical and harm-reduction guide to Methadone in India, covering its unique pharmacology, its role in Methadone Maintenance Treatment (MMT), toxicity risks, and its legal status as an Essential Narcotic Drug as of 2026.
General